The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 5,346 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 2,708 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
AMARIN CORP PLC | SPONSORED ADR | 023111206 | 12,507 | 645,000 | SH | SOLE | 645,000 | 0 | 0 | ||
AQUESTIVE THERAPEUTICS INC | COM | 03843E104 | 2,478 | 590,000 | SH | SOLE | 590,000 | 0 | 0 | ||
ARQULE INC | COM | 04269E107 | 1,101 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 4,838 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
AUDENTES THERAPEUTICS INC | COM | 05070R104 | 10,601 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
AVENUE THERAPEUTICS INC | COM NEW | 05360L205 | 5,859 | 930,000 | SH | SOLE | 930,000 | 0 | 0 | ||
AXOGEN INC | COM | 05463X106 | 17,820 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
AZURRX BIOPHARMA INC | COM | 05502L105 | 247 | 145,000 | SH | SOLE | 145,000 | 0 | 0 | ||
BIOHAVEN PHARMACEUTICAL HLDG | COM | G11196105 | 6,569 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
BIOLINERX LTD (Does not reflect a reverse stock split effectuated after June 30, 2019) | SPONSORED ADR | 09071M106 | 91 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 11,791 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
CERECOR INC | COM | 15671L109 | 11,176 | 2,185,536 | SH | SOLE | 2,185,536 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 6,350 | 1,470,000 | SH | SOLE | 1,470,000 | 0 | 0 | ||
CODEXIS INC | COM | 192005106 | 24,881 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS INC | COM | 22663K107 | 900 | 36,000 | SH | SOLE | 36,000 | 0 | 0 | ||
CYTOKINETICS | COM NEW | 23282W905 | 10,125 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 6,991 | 310,000 | SH | SOLE | 310,000 | 0 | 0 | ||
EIDOS THERAPEUTICS INC | COM | 28249H104 | 9,496 | 305,550 | SH | SOLE | 305,550 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 17,131 | 1,365,000 | SH | SOLE | 1,365,000 | 0 | 0 | ||
ETON PHARMACEUTICALS INC | COM | 29772L108 | 8,493 | 1,075,000 | SH | SOLE | 1,075,000 | 0 | 0 | ||
FENNEC PHARMACEUTICALS INC | COM | 31447P100 | 1,180 | 295,000 | SH | SOLE | 295,000 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 6,777 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
FORTRESS BIOTECH INC | COM | 034960Q19 | 3,548 | 2,365,000 | SH | SOLE | 2,365,000 | 0 | 0 | ||
HARROW HEALTH | COM | 45323A201 | 19,227 | 2,210,000 | SH | SOLE | 2,210,000 | 0 | 0 | ||
IRONWOOD PHARMACEUTICAL INC | COM CLASS A | 46333X108 | 5,748 | 525,400 | SH | SOLE | 525,400 | 0 | 0 | ||
LEXICON PHARMACEUTICALS INC | COM NEW | 528872302 | 9,309 | 1,480,000 | SH | SOLE | 1,480,000 | 0 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 7,891 | 535,000 | SH | SOLE | 535,000 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 12,980 | 2,950,000 | SH | SOLE | 2,950,000 | 0 | 0 | ||
ODONATE THERAPEUTICS INC | COM | 676079106 | 15,593 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
PROTALIX BIOTHERAPEUTICS INC | COM | 74365A101 | 469 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
PTC THERAPEUTICS INC | COM | 69366J200 | 10,187 | 226,388 | SH | SOLE | 226,388 | 0 | 0 | ||
RA PHARMACEUTICALS INC | COM | 74933V108 | 1,534 | 51,000 | SH | SOLE | 51,000 | 0 | 0 | ||
STRONGBRIDGE BIOPHARMA PLC | COM | G85347105 | 3,568 | 1,140,000 | SH | SOLE | 1,140,000 | 0 | 0 | ||
SYNTHORX INC | COM | 87167A103 | 2,129 | 157,600 | SH | SOLE | 157,600 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 9,948 | 1,150,000 | SH | SOLE | 1,150,000 | 0 | 0 | ||
TRICIDA INC | COM | 89610F101 | 7,695 | 195,000 | SH | SOLE | 195,000 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 16,021 | 205,000 | SH | SOLE | 205,000 | 0 | 0 | ||
VERMILLION INC | COM NEW | 92407M206 | 3,783 | 4,250,000 | SH | SOLE | 4,250,000 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 3,320 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
XOMA CORP DEL | COM NEW | 98419J206 | 5,944 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
ZYMEWORKS INC | COM | 98985W102 | 3,744 | 170,000 | SH | SOLE | 170,000 | 0 | 0 |